Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;14(1):5275.
doi: 10.1038/s41467-023-40965-9.

Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study

Laura Lindsay  1 , Clara Calvert  2   3 , Ting Shi  2 , Jade Carruthers  1 , Cheryl Denny  1 , Jack Donaghy  1 , Lisa E M Hopcroft  1   4 , Leanne Hopkins  1 , Anna Goulding  1   5 , Terry McLaughlin  1 , Emily Moore  1 , Bob Taylor  1 , Krishnan Bhaskaran  3 , Srinivasa Vittal Katikireddi  1   6 , Ronan McCabe  6 , Colin McCowan  7 , Colin R Simpson  2   8 , Chris Robertson  1   9 , Aziz Sheikh  2 , Rachael Wood  10   11 , Sarah J Stock  1   2
Affiliations

Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study

Laura Lindsay et al. Nat Commun. .

Abstract

Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.

PubMed Disclaimer

Conflict of interest statement

A.S. and C.R. were members of the Scottish Government’s COVID-19 Advisory Group. A.S. is a member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) risk stratification subgroup and the Scottish Government’s Committee on Pandemic Preparedness. C.R. is a member of the Scientific Pandemic Influenza Group on Modelling and the MHRA Covid 19 Vaccine Benefit and Risk Working Group. AS is a member of AstraZeneca’s Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. S.V.K. was co-chair of Scottish Government’s Expert Reference Group on Ethnicity and COVID-19. All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Adjusted odds ratios for the association between SARS-CoV-2 infection and neonatal and maternal outcomes, stratified by timing of first SARS-CoV-2 infection in the pregnancy exposure period.
The sample size for the analysis for each outcome is provided in Supplementary Table 5 and Supplementary Table 6. Odds ratios (represented by the points on the plot) were calculated using conditional logistic regression. The errors bars for each data point are 95% confidence intervals.
See this image and copyright information in PMC

References

    1. Pathirathna ML, Samarasekara BPP, Dasanayake TS, Saravanakumar P, Weerasekara I. Adverse perinatal outcomes in COVID-19 infected pregnant women: a systematic review and meta-analysis. Healthc. (Basel) 2022;10:203. - PMC - PubMed
    1. Allotey J, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320. - DOI - PMC - PubMed
    1. NHS England. Saving Babies’ Lives Version Two (NHS England, 2019).
    1. Royal College of Midwives, Royal College of Obstetricians & Gyneacologists. Coronavirus (COVID-19) Infection in Pregnancy. Information for healthcare professionals (2022). https://www.rcog.org.uk/media/xsubnsma/2022-03-07-coronavirus-covid-19-i....
    1. National Institutes of Health. COVID-19 Treatments Guidelines - Special Considerations in Prengnacy (2022). https://www.covid19treatmentguidelines.nih.gov/special-populations/pregn...].

Publication types

Substances